Last updated on April 2018

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of JTE-051 Administered for 12 Weeks in Subjects With Moderate to Severe Plaque Psoriasis (CLEAR-PS)

Brief description of study

Study to evaluate the efficacy, safety, tolerability and pharmacokinetics of JTE-051 administered for 12 weeks in subjects with moderate to severe plaque psoriasis.

Clinical Study Identifier: TX203007

Contact Investigators or Research Sites near you

Start Over

Magee McGriff

University of South Florida-Morsani College of Medicine
Tampa, FL USA
  Connect »